Premier Research (CEO Thomas Crawford Perkins) announced that it will participate in ‘BIO KOREA 5’ to be held at COEX, Seoul for three days from May 10 (Wed) to 12 (Fri).
Premier Research is a global CRO headquartered in the United States, currently providing services in 29 countries through 2,500 offices worldwide and a total of 75 employees. In 2018, it acquired ‘RPI’, a clinical trial regulatory consulting company located in San Francisco, and in 2021, it succeeded in acquiring ‘Camargo Pharmaceutical Services’ in Cincinnati, North Carolina. raised
As the proportion of biotech companies reaches 85% of all customers, it has abundant know-how in related tasks, and has the ability to perform tasks ranging from clinical trial regulatory consulting and synopsis writing to final CSR by providing a so-called ‘Full Service CRO’. side explanation.
In particular, Premier Research has excellent capabilities in the field of treatment, such as ▲Rare Disease ▲Pediatrics ▲Dermatology ▲Analgesia ▲Oncology ▲Neurology. It aims to increase the brand value and awareness of the company by introducing it to
An official from Premier Research said, “We established a Korean branch in 2018 and started providing services, and as a company with a relatively short history, we are somewhat lacking in recognition in the domestic CRO market.” As we have confirmed the high level of satisfaction from customers with services tailored to the process, we want to participate in this exhibition to meet potential customers and make our name known.”
He continued, “We will directly listen to the grievances of domestic biotech and pharmaceutical companies ahead of overseas clinical trials and propose solutions, and plan to raise domestic awareness to a level comparable to that of the United States within the next two years through active publicity and sales activities.” , “We will provide the best service so that innovative pipelines possessed by domestic companies can cross the threshold of overseas markets.”
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th this year, is hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. Since 2006, BIO KOREA, which has been striving to promote the global status and continuous growth of the Korean health industry, has been strengthening its position as Korea’s representative bio-health international convention with world-renowned scholars and business experts participating every year. BIO KOREA 2023, together with domestic and foreign companies related to the health industry such as bio, pharmaceuticals, medical devices, cosmetics, and food, as well as companies and institutions of interest such as consulting, academia, and related organizations, offers various programs such as conferences, business partnering, exhibitions, and invest fairs. It goes on.